This enduring accredited activity will focus on improving clinicians knowledge, competence, and performance in combination treatment regimens for mCRPC that contain radiopharmaceuticals. As a result of this educational activity, learners should be better able to: 1. Review the recommended role of radiopharmaceuticals in mCRPC; 2. Recognize the clinical impact of combinatorial regimens with radiopharmaceuticals in mCRPC; and, 3. Outline evidence-based strategies to personalize combination regimens with radiopharmaceuticals for mCRPC. Through this microburst learning, clinicians are provided with updated guidance on the implications of combination treatment regimens for mCRPC that contain radiopharmaceuticals and how to integrate it into clinical practice.
- Provider:Answers in CME Inc. (AiCME)
- Activity Link: https://www.answersincme.com/XWA
- Start Date: 2025-03-28 05:00:00
- End Date: 2025-03-28 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
- Commercial Support: Source: Bayer (Any division) - Amount: 228651.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Competence, Learner Knowledge
- Provider Ship: Directly Provided
- Registration: Open to all